Stem cell therapy for frailty in older adults
This trial tests a single intravenous dose of a stem cell product called Stemis™ in people aged 60 to 85 with mild to moderate frailty. The goal is to see if it is safe and tolerable, and whether it might help improve energy and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 85 years old
- You have been diagnosed with mild to moderate frailty by a doctor
- You are not planning to start any new frailty treatments during the study
- Your weight is between 88 and 198 pounds (40 to 90 kg)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a program designed for older, frail hospital patients can prevent loss of ability to do daily tasks. It focuses on physical activity, mental engagement, and nutrition to help you stay independent.
This study tests whether an experimental stem cell treatment called MiraMSC can help older adults with mild to moderate frailty. It aims to see if the treatment is safe and possibly improves energy or daily function.
This study tests an experimental stem cell product called StromaForte for people with aging frailty. It involves a single infusion of cells from a donor to see if it can improve strength and walking ability.
This study tests whether a single dose of a special stem cell treatment (HeXell-2020) is safe for older adults with mild to moderate frailty. Researchers want to see if it can help improve strength and daily function without causing serious side effects.
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
This trial aims to improve how frailty is detected in older adults. It tests a new approach to identify frailty early, which could help prevent health problems.
Hear when a new Frailty Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.